(Total Views: 493)
Posted On: 04/08/2019 10:20:13 PM
Post# of 36566
I was looking at my old blog that included some long winded words I wrote about that 2011 meeting. This made me chuckle considering this weekends posts:
“Joe helped Generex attract an impressive array of scientific experts, and he leads their business plannings, while finding accredited investors to fund their initiatives. I've had quite a few vibrant debates with him over the last few months. As Generex's plans were unveiled, I realized I had no clue to what I was talking about as I challenged him. One concern that I had expressed to Joe was how Medicares Competitive Bidding policy may affect the planned acquisition of Global Medical Direct. This concern was eased during the webcast and subsequent conference call.”
http://pipelinereview.blogspot.com/2011/04/ge...o.html?m=1
The topic of that day was the spin-off of........ Antigen Express with dividends to be awarded to shareholders. Fletcher really dropped the ball. Generex lost so much time as shareholders lost almost everything. GMD also fell apart, medicare fraud convictions, and the remaining assets purchased for $13 mill but sales didn’t warrant the purchase. The two owners, Corso and Franz, are locked in a lawsuit detailing their demise:
https://www.leagle.com/decision/infdco20180328g65
Fletcher was going to dilute Gnbt to dust to make that acquisition. Joe couldn’t be any more different. No dilution for Veneto. AE NGIO dividends already awarded. Multiple deals in place or pending. To bad they didn’t just put Joe in and pass over Mark back then.
“Joe helped Generex attract an impressive array of scientific experts, and he leads their business plannings, while finding accredited investors to fund their initiatives. I've had quite a few vibrant debates with him over the last few months. As Generex's plans were unveiled, I realized I had no clue to what I was talking about as I challenged him. One concern that I had expressed to Joe was how Medicares Competitive Bidding policy may affect the planned acquisition of Global Medical Direct. This concern was eased during the webcast and subsequent conference call.”
http://pipelinereview.blogspot.com/2011/04/ge...o.html?m=1
The topic of that day was the spin-off of........ Antigen Express with dividends to be awarded to shareholders. Fletcher really dropped the ball. Generex lost so much time as shareholders lost almost everything. GMD also fell apart, medicare fraud convictions, and the remaining assets purchased for $13 mill but sales didn’t warrant the purchase. The two owners, Corso and Franz, are locked in a lawsuit detailing their demise:
https://www.leagle.com/decision/infdco20180328g65
Fletcher was going to dilute Gnbt to dust to make that acquisition. Joe couldn’t be any more different. No dilution for Veneto. AE NGIO dividends already awarded. Multiple deals in place or pending. To bad they didn’t just put Joe in and pass over Mark back then.
(1)
(0)
